TGOD.TO C$0.17 intraday 02 Jan 2026: 19.70M shares traded, watch liquidity
TGOD.TO stock opened at C$0.26 and is trading at C$0.17 intraday on the TSX on 02 Jan 2026, with heavy activity of 19,704,275 shares, or a relative volume of 12.43 compared with the 1,585,835 average. The intraday range is C$0.17 to C$0.22 while the 50-day average remains above at C$0.24 and the 200-day average at C$0.31, underscoring that current trading sits well below medium and long-term averages on strong turnover.
Intraday price action and volume
The Green Organic Dutchman Holdings Ltd. (TGOD.TO) is one of the most active TSX names intraday after printing a high of C$0.22 and a low of C$0.17 while volume surged to 19,704,275 shares versus an average of 1,585,835, signaling outsized trading interest and liquidity shifts in the healthcare/drug manufacturers group.
Fundamentals snapshot
TGOD.TO reports EPS of -0.23 and a negative PE near -0.74, reflecting recent losses, while revenue per share is C$0.06 and book value per share is C$0.38, giving a price-to-book of roughly 0.45 which implies the market values the company below stated equity on a per-share basis.
Valuation and key ratios
Enterprise value stands near C$35,113,000 with EV/Sales about 1.63 and gross margin about 28.44%, but operating margin is -8.23% and net margin -8.52%, highlighting negative profitability despite reasonable gross margins; current ratio is 0.67 and debt-to-equity is 0.33, showing modest leverage but tight short-term liquidity.
Technicals and Meyka grade
Technically TGOD.TO is trading below its 50-day (C$0.24) and 200-day (C$0.31) averages and shows an average true range of C$0.05, indicating intraday volatility relative to price. Meyka AI rates TGOD.TO with a score out of 100: 43 (C, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Risks and near-term opportunities
Key risks include continued negative operating cash flow per share of -C$0.10, lengthy inventory days of 453 and payables days of 580 which point to working-capital distortions; opportunities include brand exposure in organic cannabis segments and a low price-to-book that could attract value-oriented speculation if earnings recover.
Outlook and forecast
Meyka AI’s forecast model projects a monthly price of C$0.17 versus the current C$0.17, implying 0.00% near-term change from the model baseline; given the large gap to the 12-month highs of C$0.65, scenarios are binary: recovery with margin improvement or continued consolidation. For broader industry context see MarketBeat coverage of peers MarketBeat.
Final Thoughts
TGOD.TO is trading as a high-volume, low-price TSX equity at C$0.17 on 02 Jan 2026 with 19,704,275 shares changing hands intraday, placing it on the most-active list for Canada’s healthcare/drug manufacturers group. Fundamentals show a mixed picture: a modest book value per share of C$0.38 and EV/Sales of 1.63 sit against negative EPS (-C$0.23) and weak operating margins, and liquidity metrics such as a 0.67 current ratio underline short-term stress. From a trading lens, heavy volume and a relative volume of 12.43 create short-term liquidity and volatility opportunities, but the stock remains below both the 50-day and 200-day averages, which argues for caution. Meyka AI’s forecast model projects a monthly price of C$0.17 versus today’s C$0.17, implying a 0.00% change from the model baseline; forecasts are model-based projections and not guarantees. Investors should weigh downside risk from cash-flow weakness and inventory dynamics against potential upside if margins or demand for organic cannabis improve. For peer comparisons and sector trends visit MarketBeat sector summaries MarketBeat. Meyka AI, an AI-powered market analysis platform, provides this data-driven snapshot to help frame near-term trading and longer-term research.
FAQs
TGOD.TO is trading at C$0.17 intraday on 02 Jan 2026 with volume 19,704,275, well above its average; high volume reflects trader interest and liquidity rather than a change in fundamentals.
Key risks include negative operating cash flow per share (-C$0.10), low current ratio (0.67), long inventory days (453) and negative margins, which raise short-term liquidity and profitability concerns.
Meyka AI’s forecast model projects a monthly price of C$0.17 versus the current C$0.17, implying 0.00% near-term change; forecasts are model-based projections and not guarantees.
Traders should monitor volume and price relative to intraday ranges (C$0.17–C$0.22) and manage risk given high volatility and trading interest; keep stop levels tight and size positions accordingly.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
